This study conducted a cross-sectional analysis of 13,037 Chinese patients without a history of Hp treatment who underwent gastrointestinal endoscopy at The First Affiliated Hospital of Zhejiang Chinese Medical University from 2018.1-2019.12 to clarify whether Hp is a risk factor for CPs and CRC, and whether Hp-positive Chinese patients need to undergo colonoscopy screening earlier. The gene discussed is HP; the disease is colorectal carcinoma.